1359704-84-9 Usage
General Description
Tert-butyl 2-oxo-6-azaspiro[3.5]nonane-6-carboxylate is a chemical compound with the molecular formula C12H19NO3. It is a spirocyclic compound that contains a tert-butyl group, an oxo group, and a carboxylate group. tert-butyl 2-oxo-6-azaspiro[3.5]nonane-6-carboxylate is often used in organic synthesis and medicinal chemistry as a building block for the synthesis of various pharmaceuticals and bioactive compounds. Its unique spirocyclic structure and functional groups make it a valuable intermediate for the preparation of complex molecules. Tert-butyl 2-oxo-6-azaspiro[3.5]nonane-6-carboxylate is also used as a research tool in the study of biological processes and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 1359704-84-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,9,7,0 and 4 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1359704-84:
(9*1)+(8*3)+(7*5)+(6*9)+(5*7)+(4*0)+(3*4)+(2*8)+(1*4)=189
189 % 10 = 9
So 1359704-84-9 is a valid CAS Registry Number.
1359704-84-9Relevant articles and documents
Stereoselective Diboration of Spirocyclobutenes: A Platform for the Synthesis of Spirocycles with Orthogonal Exit Vectors
Nóvoa, Luis,Trulli, Laura,Parra, Alejandro,Tortosa, Mariola
, p. 11763 - 11768 (2021/04/26)
The diastereo- and enantioselective diboration of spirocyclobutenes provides a platform for the rapid preparation of a wide variety of chiral spirocyclic building blocks. The chemoselective functionalization of the carbon-boron bond in the products, including a stereospecific sp3-sp2 Suzuki–Miyaura cross-coupling reaction, provides a powerful tool to control the directionality and the nature of the exit vectors in the spirocyclic framework.
SPIROCYCLIC MOLECULES AS PROTEIN KINASE INHIBITORS
-
Paragraph 00256-00258, (2013/03/26)
The present invention relates to spirocyclic compounds of formula I, namely spirocyclic (1H-pyrazol-4-yl)-3-(1-(2,6-dichloro-3-fiuorophenyl) ethoxy)pyridin-2-amines having protein kinase inhibitory activity, and methods of synthesizing and using such compounds. Preferred compounds are c-Met and/or ALK inhibitors useful for the treatment of abnormal cell growth, such as cancers
